Strides Pharma Science Share Price

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.As of 25 May 2026, Strides Pharma Science share price is ₹1,188.10. The stock opened at ₹1,144.00, compared to its previous close of ₹1,153.20. During today's trading session, Strides Pharma Science share price moved in the range of ₹1,144.00 to ₹1,195.00, with an average price of ₹1,169.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,144.00 and a high of ₹1,195.00. On the performance front, Strides Pharma Science share price has increased by 34.14% over the last six months and is up 62.39% on a year-on-year basis.

The market capitalization of Strides Pharma Science is ₹10,628 Crs, with a P/E ratio of 18.5 and a dividend yield of 0.43%.